New imaging technique offers "quantum leap" in sensitivity
This article was originally published in Clinica
Executive Summary
"Disguising" a contrast agent as a peptide could dramatically improve the agent's sensitivity and specificity for detecting breast cancer. Such is the theory of a US research team, which is developing a hand-held, near-infrared sensor to pick up signals released by the agent when enzymes in malignant cells break down the peptide. The method of detection could "far exceed all other imaging modalities", team leader Britton Chance of the University of Pennsylvania, told Clinica.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.